Standout Papers
Citation Impact
Citing Papers
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: A Single Center Study of Epidemiologic Migration-Specific and Clinical Features
2004
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis
2010
Expanding global access to radiotherapy
2015 Standout
Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa
2006
Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis
2015
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
2008 Standout
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
2017 Standout
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia
2006 StandoutNobel
Risk Factors and Mortality Associated With Resistance to First-Line Antiretroviral Therapy
2015
HIV and Africa's elderly
2012
New insights into HIV epidemic in South Africa: key findings from the National HIV Prevalence, Incidence and Behaviour Survey, 2012
2016 Standout
Morbidity and Mortality According to Latest CD4+ Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa
2015
The risk of transfusion‐transmitted infections in sub‐Saharan Africa
2009
The end of AIDS: HIV infection as a chronic disease
2013 Standout
A Decline in New HIV Infections in South Africa: Estimating HIV Incidence from Three National HIV Surveys in 2002, 2005 and 2008
2010
Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study
2009
Sickle-cell disease
2010 Standout
How Soon after Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold Miners
2004
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
2008
<p>Antimicrobial Resistance: Implications and Costs</p>
2019 Standout
Earlier initiation of antiretroviral therapy in treatment-na??ve patients: implications of results of treatment interruption trials
2008
Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
2011
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
HIV Viral Load Monitoring in Resource‐Limited Regions: Optional or Necessary?
2006
Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks
2006 StandoutNobel
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
5′‐Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice
2006 StandoutNobel
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world
2011
Common Variation in NLRP3 Is Associated With Early Death and Elevated Inflammasome Biomarkers Among Advanced HIV/TB Co-infected Patients in Botswana
2018 StandoutNobel
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Trends in CD4 Count at Presentation to Care and Treatment Initiation in Sub-Saharan Africa, 2002–2013: A Meta-analysis
2014
Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS
2003 Science
Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up
2008
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings
2010
The Immune Response in Tuberculosis
2013 Standout
Point-of-Care Diagnostics for Global Health
2008 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized
2016
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa
2008
The Engagement of Activating FcγRs Inhibits Primate Lentivirus Replication in Human Macrophages
2006 StandoutNobel
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting
2005
Works of Albert Minga being referenced
HIV-1 Antiretroviral Drug Resistance in Recently Infected Patients in Abidjan, Côte d'Ivoire: A 4-Year Survey, 2002–2006
2007
Presence of Key Drug Resistance Mutations in Isolates from Untreated Patients of Abidjan, Côte d'Ivoire: ANRS 1257 Study
2003
Clinical and Biological Evolution of HIV-1 Seroconverters in Abidjan, Côte d'Ivoire, 1997–2000
2002 StandoutNobel
Mortality, AIDS-Morbidity, and Loss to Follow-up by Current CD4 Cell Count Among HIV-1–Infected Adults Receiving Antiretroviral Therapy in Africa and Asia
2012
Field Evaluation of an Improved Assay Using a Heat-Dissociated p24 Antigen for Adults Mainly Infected With HIV-1 CRF02_AG Strains in C??te d'Ivoire, West Africa
2003
Psychosocial correlates of inconsistent condom use among HIV-infected patients enrolled in a structured ART interruptions trial in Côte d’Ivoire: results from the TRIVACAN trial (ANRS 1269)
2010
Do Tests Devised to Detect Recent HIV-1 Infection Provide Reliable Estimates of Incidence in Africa?
2007
Increasing Rate of TAMs and Etravirine Resistance in HIV-1–Infected Adults Between 12 and 24 Months of Treatment
2013
CD4-Specific Mortality Rates Among HIV-Infected Adults With High CD4 Counts and No Antiretroviral Treatment in West Africa
2011
Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Côte d'Ivoire
2010
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
2008
Haematological Changes in Adults Receiving a Zidovudine-Containing Haart Regimen in Combination with Cotrimoxazole in Côte D'ivoire
2005
AIDS and Non-AIDS Morbidity and Mortality Across the Spectrum of CD4 Cell Counts in HIV-Infected Adults Before Starting Antiretroviral Therapy in Côte d’Ivoire
2011